Briseno Andres Ruiz
CIK: 0001983118
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IDEAYA Biosciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 7, 2026IDYA
IDEAYA Biosciences, Inc.
Exercise(M)Direct9.6K shares at avg. $12.86$123K - Jul 7, 2026IDYA
IDEAYA Biosciences, Inc.
Sale(S)Direct9.6K shares at avg. $40.01$382K - Jan 30, 2026IDYA
IDEAYA Biosciences, Inc.
Award(A)DirectStock Option (right to buy)
80K shares- - Nov 28, 2025IDYA
IDEAYA Biosciences, Inc.
Award(A)Direct1.3K shares at avg. $16.91$21K - Feb 27, 2025IDYA
IDEAYA Biosciences, Inc.
Award(A)DirectStock Option (right to buy)
75K shares- - Nov 29, 2024IDYA
IDEAYA Biosciences, Inc.
Award(A)Direct682 shares at avg. $23.26$16K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 7, 2026 | IDYA IDEAYA Biosciences, Inc. | Exercise(M) | 9,550 | $12.86 | $122,813 | Direct |
| Jul 7, 2026 | IDYA IDEAYA Biosciences, Inc. | Sale(S) | 9,550 | $40.01 | $382,131 | Direct |
| Jan 30, 2026 | IDYA IDEAYA Biosciences, Inc. | Award(A) Stock Option (right to buy) | 80,000 | - | - | Direct |
| Nov 28, 2025 | IDYA IDEAYA Biosciences, Inc. | Award(A) | 1,253 | $16.91 | $21,184 | Direct |
| Feb 27, 2025 | IDYA IDEAYA Biosciences, Inc. | Award(A) Stock Option (right to buy) | 75,000 | - | - | Direct |
| Nov 29, 2024 | IDYA IDEAYA Biosciences, Inc. | Award(A) | 682 | $23.26 | $15,861 | Direct |
1-6 of 6 transactions
About Ruiz Briseno Andres
Ruiz Briseno Andres (SEC CIK 0001983118) files insider reports with the SEC as Chief Accounting Officer of IDEAYA Biosciences, Inc. (IDYA).
Signal8 holds 3 ownership filings by Ruiz Briseno Andres, all Form 4s, filed between Feb 28, 2025 and Jul 9, 2026. Those filings report 6 transactions, from Nov 29, 2024 to Jul 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ruiz Briseno Andres's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Ruiz Briseno Andres
- Jul 7, 2026: Option exercise of IDYA shares (Form 4, code M).
- Jul 7, 2026: Open-market sale of IDYA shares (Form 4, code S).
- Jan 30, 2026: Grant or award of IDYA derivative securities (Form 4, code A).
- Nov 28, 2025: Grant or award of IDYA shares (Form 4, code A).
- Feb 27, 2025: Grant or award of IDYA derivative securities (Form 4, code A).
Other insiders filing for IDEAYA Biosciences, Inc. (IDYA)
- Hata Yujiro S, President and CEO
- YARNO WENDY L, Director
- Stein Jeffrey, Director
- ROSEN TERRY J, Director
- Morrison Scott W, Director
- MACKEY CATHERINE J, Director